Palbociclib in advanced breast cancer: A cost-utility analysis

被引：0
|
作者：
Raphael, J. [1 ]
Helou, J. [1 ]
Naimark, D. M. [1 ]
机构：
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1116P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis
    Raphael, J.
    Helou, J.
    Pritchard, K. I.
    Naimark, D. M.
    EUROPEAN JOURNAL OF CANCER, 2017, 85 : 146 - 154
  • [2] Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis
    Raphael, Jacques
    Helou, Joelle
    Naimark, David M.
    CANCER RESEARCH, 2018, 78 (04)
  • [3] Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
    Michael Patrick Lux
    M. Hartmann
    C. Jackisch
    G. Raab
    A. Schneeweiß
    K. Possinger
    J. Oyee
    N. Harbeck
    Breast Cancer Research and Treatment, 2009, 117 : 305 - 317
  • [4] COST-UTILITY ANALYSIS OF ADJUVANT THERAPIES FOR BREAST CANCER IN IRAN
    Bastani, Peivand
    Kiadaliri, Aliasghar Ahmed
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (02) : 110 - 114
  • [5] Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model
    Lux, Michael Patrick
    Hartmann, M.
    Jackisch, C.
    Raab, G.
    Schneeweiss, A.
    Possinger, K.
    Oyee, J.
    Harbeck, N.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 305 - 317
  • [6] Cost-utility analysis of lapatinib in treatment of HER2-positive advanced breast cancer
    Le, Q. A.
    Hay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients
    Brown, RE
    Hutton, J
    ANTI-CANCER DRUGS, 1998, 9 (10) : 899 - 907
  • [8] COST-UTILITY ANALYSIS OF CANCER CARE
    OESER, H
    KOEPPE, P
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (09): : A38 - &
  • [9] A cost-utility analysis of Fulvestrant in treating recurrent metastatic breast cancer
    Park, S. Y.
    Kang, H. H.
    Noh, E.
    Lee, E. K.
    VALUE IN HEALTH, 2008, 11 (03) : A71 - A71
  • [10] Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis
    Spolverato, Gaya
    Vitale, Alessandro
    Bagante, Fabio
    Connolly, Roisin
    Pawlik, Timothy M.
    ANNALS OF SURGERY, 2017, 265 (04) : 792 - 799
12345